Medtronic Inc (NYSE:MDT) | Medtronic settles heart valve patent fight with Edwards

[Reuters] – Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday. The settlement . . . → Read More: Medtronic Inc (NYSE:MDT) | Medtronic settles heart valve patent fight with Edwards Similar Articles: Market Update: Medtronic Inc (NYSE:MDT) – Medtronic Names Hooman Hakami Executive Vice President and Group President of the Medtronic Diabetes Group Company Update (NYSE:MDT): Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.